News | May 07, 2023
Lupin to acquire French pharmaceutical company Medisol
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Bridging the gap between histopathology and molecular pathology
Subscribe To Our Newsletter & Stay Updated
